secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canton Strategic Holdings, Inc. (CNTN)
CIK:        0001861657
Form:       8-K
Filed at:   2026-07-23T12:40:28+00:00
Accession:  0001493152-26-034340
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Canton Strategic sells Gravitas Life Sciences for $3.5M note; focuses on Canton Network
--------------------------------------------------------------------------------

- Sold 100% of Gravitas Life Sciences to Gravitas Collective Corp. for $3.5M unsecured promissory note (15% interest, matures July 2029) plus milestone payments.
- Buyer affiliated with former directors Vincent LoPriore, Sireesh Appajosyula, Gary Stetz; transaction approved by special committee.
- Company retains bispecific antibodies assets via Tharimmune SPV1; pro forma shows reduced operating losses (Q1 2026 net loss improves from $47.3M to $45.5M).
- Divestiture aligns with transition to operating company driving digitization of financial markets via Canton Network; locking service launched June 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861657/000149315226034340/0001493152-26-034340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861657/000149315226034340/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-034340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer